Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Amin

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Annals of Neurology|March 2, 2016
Outcome and recurrence 1 year after pediatric arterial ischemic stroke in a population-based cohortAndrew A Mallick, Vijeya Ganesan, Fenella J Kirkham, et al.
The Lancet. Neurology|April 16, 2022
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trialElia M Pestana Knight, Sam Amin, Nadia Bahi-Buisson, et al.
Frontiers in Neurology|July 7, 2022
International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency DisorderSam Amin, Marie Monaghan, Angel Aledo-Serrano, et al.
Developmental Medicine and Child Neurology|July 17, 2024
UK research priority setting for childhood neurological conditionsJill Cadwgan, Jane Goodwin, Barbara Babcock, et al.
American Journal of Human Genetics|October 7, 2022
De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movementShenzhao Lu, Mengqi Ma, Xiao Mao, et al.
Archives of Disease in Childhood|April 15, 2021
Intrathecal baclofen pumps in the management of hypertonia in childhood: a UK and Ireland wide surveyRajib Lodh, Sam Amin, Amr Ammar, et al.
Pediatric Neurology|June 1, 2019
Severity Assessment in CDKL5 Deficiency DisorderScott Demarest, Elia M Pestana-Knight, Heather E Olson, et al.
American Journal of Human Genetics|April 28, 2021
Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphismMaya Chopra, Meriel McEntagart, Jill Clayton-Smith, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Annals of Neurology|March 2, 2016
Outcome and recurrence 1 year after pediatric arterial ischemic stroke in a population-based cohortAndrew A Mallick, Vijeya Ganesan, Fenella J Kirkham, et al.
The Lancet. Neurology|April 16, 2022
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trialElia M Pestana Knight, Sam Amin, Nadia Bahi-Buisson, et al.
Frontiers in Neurology|July 7, 2022
International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency DisorderSam Amin, Marie Monaghan, Angel Aledo-Serrano, et al.
Developmental Medicine and Child Neurology|July 17, 2024
UK research priority setting for childhood neurological conditionsJill Cadwgan, Jane Goodwin, Barbara Babcock, et al.
American Journal of Human Genetics|October 7, 2022
De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movementShenzhao Lu, Mengqi Ma, Xiao Mao, et al.
Archives of Disease in Childhood|April 15, 2021
Intrathecal baclofen pumps in the management of hypertonia in childhood: a UK and Ireland wide surveyRajib Lodh, Sam Amin, Amr Ammar, et al.
Pediatric Neurology|June 1, 2019
Severity Assessment in CDKL5 Deficiency DisorderScott Demarest, Elia M Pestana-Knight, Heather E Olson, et al.
American Journal of Human Genetics|April 28, 2021
Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphismMaya Chopra, Meriel McEntagart, Jill Clayton-Smith, et al.
Pageof 3